Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) [U01]

The summary for the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) [U01] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) [U01]: Purpose. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH) invite applications from investigators willing to participate with NICHD, NIDA, and NIMH under a cooperative agreement to support the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). The primary mission of the ATN will be to conduct research, both independently and in collaboration with existing research networks and individual investigators, in HIV-infected and HIV-at-risk pre-adolescents, adolescents, and young adults up to age 25 years. This network will have the capacity for developing and conducting selected behavioral, community-based translational, prophylactic, therapeutic, microbicide and vaccine trials. Mechanism of Support. This FOA will utilize the NIH Cooperative Research Project Grant (U01) grant mechanism. Funds Available and Anticipated Number of Awards. The NICHD intends to commit an approximate minimum of $22.5 million, NIDA intends to commit $1 million, and NIMH intends to commit $1 million in total costs [Direct plus Facilities and Administrative (F and A) costs] in FY 2011 to support 17 to 19 new and/or competing continuation grants in response to this FOA.
Federal Grant Title: Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) [U01]
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HD-10-015
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: Apr 14, 2010
Original Application Deadline: Apr 14, 2010
Posted Date: Jan 20, 2010
Creation Date: Jan 20, 2010
Archive Date: May 15, 2010
Total Program Funding: $22,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs).
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R...
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R...
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Ad...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com